Q3 2023 Holdings
Filed 2023-11-14 | 52 holdings | $117.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $41.6M | 716,297 | 35.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $8.7M | 77,240 | 7.4% |
| Biodesix Inc | COM | 09075X108 | $8.5M | 5,193,336 | 7.3% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $8.2M | 169,574 | 7.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $5.0M | 240,400 | 4.3% |
| Quidelortho Corp | COM | 74838J101 | $4.8M | 65,203 | 4.1% |
| Ovintiv Inc(OVV) | COM | 69047Q102 | $4.0M | 84,200 | 3.4% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $3.0M | 190,000 | 2.6% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $2.5M | 11,000 | 2.1% |
| Elutia Inc(ELUT) | COM | 05479K106 | $2.4M | 1,655,184 | 2.0% |
| Harrow Health Inc(HROW) | COM | 415858109 | $2.2M | 150,000 | 1.8% |
| Phreesia Inc(PHR) | COM | 71944F106 | $1.5M | 82,700 | 1.3% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.4M | 50,000 | 1.2% |
| Bluebird BIO Inc | COM | 09609G100 | $1.4M | 455,200 | 1.2% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $1.4M | 50,000 | 1.2% |
| Masimo Corp(MASI) | COM | 574795100 | $1.3M | 15,280 | 1.1% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $1.3M | 264,843 | 1.1% |
| Accelerate Diagnostics Inc | COM | 00430H102 | $1.3M | 225,239 | 1.1% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $1.3M | 70,448 | 1.1% |
| Equitrans Midstream Corporatio(ETRNUSD) | COM | 294600101 | $1.2M | 133,050 | 1.1% |
| Alphatec Holdings Inc(ATEC) | COM | 02081G201 | $1.0M | 80,000 | 0.9% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $916.9K | 26,400 | 0.8% |
| Pioneer Natural Resources Co(PXDEUR) | COM | 723787107 | $872.3K | 3,800 | 0.7% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $866.3K | 21,000 | 0.7% |
| Axogen Inc(AXGN) | COM | 05463X106 | $865.0K | 173,000 | 0.7% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $766.3K | 571,832 | 0.7% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $736.5K | 25,000 | 0.6% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $733.1K | 82,000 | 0.6% |
| Docgo Inc(DCGO) | COM | 256086109 | $692.9K | 130,000 | 0.6% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $684.7K | 18,000 | 0.6% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $633.8K | 38,000 | 0.5% |
| Silk Road Medical Inc | COM | 82710M100 | $619.0K | 41,294 | 0.5% |
| Progyny Inc(PGNY) | COM | 74340E103 | $612.4K | 18,000 | 0.5% |
| Kiniksa Pharmaceuticals LTD | COM | G5269C101 | $521.1K | 30,000 | 0.4% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $385.2K | 40,000 | 0.3% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $382.0K | 10,000 | 0.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $341.6K | 10,000 | 0.3% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $340.5K | 28,000 | 0.3% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $334.9K | 85,000 | 0.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $303.1K | 2,500 | 0.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $294.6K | 15,000 | 0.3% |
| Xencor Inc(XNCR) | COM | 98401F105 | $247.8K | 12,300 | 0.2% |
| 2Seventy BIO Inc(TSVT*) | COM | 901384107 | $234.5K | 59,833 | 0.2% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $227.3K | 25,114 | 0.2% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $223.2K | 7,000 | 0.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $174.1K | 209,088 | 0.1% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $172.8K | 120,000 | 0.1% |
| Inflarx NV(IFRX) | COM | N44821101 | $149.0K | 50,000 | 0.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $141.6K | 20,000 | 0.1% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $16.7K | 28,000 | 0.0% |